Literature DB >> 9326989

Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.

R Kaulitz1, I Luhmer, F Bergmann, B Rodeck, G Hausdorf.   

Abstract

OBJECTIVE: To investigate the specific sequelae of the Fontan operation, and particularly the potential sequelae of chronically elevated systemic venous pressure.
DESIGN: A retrospective analysis of clinical and haemodynamic data and evaluation of organ function in 80 surviving patients undergoing modified Fontan operation for various forms of underlying functionally univentricular hearts. PATIENTS: 65 patients (81%) who had undergone a total cavopulmonary anastomosis and 15 an atriopulmonary anastomosis. Follow up ranged from 12 to 106 months (mean 54 (SD 23) months).
RESULTS: 62 patients underwent postoperative cardiac catheterisation (mean systemic venous pressure 10.5 (2.5) mm Hg and cardiac index 3.1 (0.7) l/min/m2). Older age at operation was significantly correlated with both higher systemic venous pressure and lower cardiac index. Atrial arrhythmia was documented on Holter electrocardiogram in 17%. Protein losing enteropathy (with abnormal alpha 1-antitrypsin clearance) was found in 2/80 patients (2.5%). Ten patients had hypoproteinaemia, with a significantly higher incidence in patients after total cavopulmonary anastomosis and young age at operation. Liver function tests reflecting liver synthesis and metabolism were normal in all, whereas mild cholestasis was found in nearly 30%-predominantly in patients with a cardiac index of < 3 l/min/m2 (P = 0.045). Five patients (6.2%) developed atrial thrombosis. Coagulation factor analysis in 44 patients showed protein C deficiency in 11 (25%); laboratory signs of activation of the coagulation system were found in four of these (9%). None of the abnormal laboratory indices was significantly related to underlying cardiac malformation, postoperative systemic venous pressure, or follow up interval.
CONCLUSIONS: A high proportion of clinically asymptomatic patients had abnormal laboratory findings on mid-term follow up. Detailed evaluation of organ function is necessary to detect the need for further diagnostic procedures before clinical symptoms develop.

Entities:  

Mesh:

Year:  1997        PMID: 9326989      PMCID: PMC484895          DOI: 10.1136/hrt.78.2.154

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  21 in total

1.  Outcome after a "perfect" Fontan operation.

Authors:  F Fontan; J W Kirklin; G Fernandez; F Costa; D C Naftel; F Tritto; E H Blackstone
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

2.  Atrial thrombi after the Fontan operation.

Authors:  A R Dobell; G A Trusler; J F Smallhorn; W G Williams
Journal:  Ann Thorac Surg       Date:  1986-12       Impact factor: 4.330

3.  Thrombolytic treatment with streptokinase for late intraatrial thrombosis after modified Fontan procedure.

Authors:  L Mahony; H Nikaidoh; D E Fixler
Journal:  Am J Cardiol       Date:  1988-08-01       Impact factor: 2.778

Review 4.  Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism.

Authors:  B Dahlbäck
Journal:  Blood       Date:  1995-02-01       Impact factor: 22.113

5.  Predictors of rhythm disturbances and subsequent morbidity after the Fontan operation.

Authors:  H S Weber; W E Hellenbrand; C S Kleinman; R A Perlmutter; L E Rosenfeld
Journal:  Am J Cardiol       Date:  1989-10-01       Impact factor: 2.778

6.  Risk factors for atrial tachyarrhythmias after the Fontan operation.

Authors:  M Gelatt; R M Hamilton; B W McCrindle; R M Gow; W G Williams; G A Trusler; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1994-12       Impact factor: 24.094

7.  Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle.

Authors:  J E Mayer; N D Bridges; J E Lock; F L Hanley; R A Jonas; A R Castaneda
Journal:  J Thorac Cardiovasc Surg       Date:  1992-03       Impact factor: 5.209

8.  Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience.

Authors:  M R de Leval; P Kilner; M Gewillig; C Bull
Journal:  J Thorac Cardiovasc Surg       Date:  1988-11       Impact factor: 5.209

9.  Protein-losing enteropathy after Fontan operation.

Authors:  J Hess; K Kruizinga; C M Bijleveld; R Hardjowijono; A Eygelaar
Journal:  J Thorac Cardiovasc Surg       Date:  1984-10       Impact factor: 5.209

10.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

Authors:  J A Hoek; A Sturk; J W ten Cate; R J Lamping; F Berends; J J Borm
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

View more
  23 in total

1.  Permanent ventricular pacing from coronary sinus after Fontan operation using newly designed left ventricular lead.

Authors:  Katherine Fan; Tak-Cheung Yung
Journal:  J Interv Card Electrophysiol       Date:  2002-08       Impact factor: 1.900

2.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

3.  Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.

Authors:  Ari Cedars; Susan Joseph; Philip Ludbrook
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

4.  Serial evaluation of hepatic function profile after Fontan operation.

Authors:  R Kaulitz; P Haber; E Sturm; J Schäfer; M Hofbeck
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

5.  Hepatic pathology after Fontan palliation: spectrum of imaging findings.

Authors:  Daniel B Wallihan; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-10-06

Review 6.  Congenital heart disease: current indications for antithrombotic therapy in pediatric patients.

Authors:  M D Reller
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

7.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

8.  Thromboelastography of patients after fontan compared with healthy children.

Authors:  Leslie Raffini; Alexander Schwed; X Long Zheng; Maria Tanzer; Susan Nicolson; J William Gaynor; David Jobes
Journal:  Pediatr Cardiol       Date:  2009-04-09       Impact factor: 1.655

9.  Serum alkaline phosphatase reflects post-Fontan hemodynamics in children.

Authors:  Alvin J Chin; P Stephens; E Goldmuntz; M B Leonard
Journal:  Pediatr Cardiol       Date:  2008-08-07       Impact factor: 1.655

10.  Older Age at Completion of Fontan Procedure Is Associated with Improved Percentage of Predicted Maximum Oxygen Uptake.

Authors:  Elijah H Bolin; Shiraz A Maskatia; Amanda L Tate; Christopher J Petit
Journal:  Tex Heart Inst J       Date:  2015-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.